Crolom

Active Ingredient(s): Cromolyn Sodium
FDA Approved: * January 30, 1995
Pharm Company: * BAUSCH AND LOMB
Category: Asthma

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Crolom Overview

Cromoglicic acid (INN) (also referred to as cromolyn (USAN), cromoglycate (former BAN), or cromoglicate) is traditionally described as a mast cell stabilizer, and is commonly marketed as the sodium salt sodium cromoglicate or cromolyn sodium. This drug prevents the release of inflammatory chemicals such as histamine from mast cells. Cromoglicic acid has been the non-corticosteroid treatment of choice in the treatment of asthma, for which it has largely been replaced by leukotriene receptor a...

Read more Crolom Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cromoglicic_acid

Recent Crolom Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Crolom: (1 result)

Sorted by National Drug Code

• 24208-300 Crolom 40 mg/ml Ophthalmic Solution/ Drops by Bausch & Lomb Incorporated

Other drugs which contain Cromolyn Sodium or a similar ingredient: (7 results)

• CROMOLYN SODIUM 1 discussion
• CROMOPTIC Cromolyn Sodium
• GASTROCROM Cromolyn Sodium6 discussions
• INTAL Cromolyn Sodium
• INTAL INHALER Cromolyn Sodium
• NASALCROM Cromolyn Sodium1 discussion
• OPTICROM Cromolyn Sodium